Log in to save to my catalogue

Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efav...

Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efav...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_18892fbe445c45b6946a62734fa30727

Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial

About this item

Full title

Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial

Publisher

England: BioMed Central Ltd

Journal title

BMC Pregnancy and Childbirth, 2023-01, Vol.23 (1), p.34-13, Article 34

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

This exploratory analysis investigates the prevalence and risk factors of neurocognitive toxicity in postpartum women on HIV treatment in response to a concern of an Isoniazid Preventive Therapy (IPT)/Efavirenz interaction.
Pregnant women on HIV treatment from countries with high TB prevalence were randomized in IMPAACT P1078 to 28 weeks of IPT...

Alternative Titles

Full title

Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_18892fbe445c45b6946a62734fa30727

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_18892fbe445c45b6946a62734fa30727

Other Identifiers

ISSN

1471-2393

E-ISSN

1471-2393

DOI

10.1186/s12884-022-05341-3

How to access this item